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Abstract
Background: Within the past 10 years, methicillin-resistant Staphylococcus aureus (MRSA) has not only been a hospital
pathogen but also a community pathogen. To understand the carriage rate of methicillin-resistant Staphylococcus aureus
(MRSA) among the adult patients visiting emergency department (ED), we conducted this study.
Methodology/Principal Findings: From May 21 to August 12, 2009, a total of 502 adult patients visiting emergency
department (ED) of a tertiary care hospital in northern Taiwan were recruited in this study and surveyed for nasal carriage of
MRSA. A questionnaire regarding the risk factors for MRSA acquisition was also obtained. The overall prevalence of MRSA
nasal carriage among the patients was 3.8%. The carriage rate was significantly higher in patients with risk factors for MRSA
acquisition (5.94%) than those without risk factors (2.12%). Patients with urinary complaints, diabetes mellitus, chronic
kidney disease and current percutaneous tube usage were significantly associated with MRSA colonization. By multiple
logistic regression analysis, only current usage of catheters or tubes was the independent predictor for MRSA nasal
colonization. Of the 19 MRSA, most isolates belonged to one of two linages, characterized as sequence type (ST) 239 (32%)
and ST 59 (58%). The latter linage, accounting for 83% of 6 isolates from patients without risk factors, is a community-
associated (CA) clone in Taiwan, while the former linage is among healthcare-associated clones.
Conclusion/Significance: A substantial proportion of patients visiting ED, particularly with current usage of percutaneous
catheter or tubes, in northern Taiwan carried MRSA, mostly community strains, in nares.
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Introduction
Staphylococcus aureus is an important pathogen in humans and
causes a broad spectrum of diseases, ranging from skin and soft
tissue infection, myositis, bone/joint infection, pneumonia, endo-
carditis, bacteremia, to life-threatening infections of septicemia,
necrotizing fasciitis, and toxic shock syndrome [1]. It is always a
challenge to treat infections due to S. aureus, particularly isolates
resistant to methicillin (methicillin-resistant S. aureus, MRSA) and
related beta-lactams. Nowadays, MRSA is endemic in most
hospitals in the world and accounts for 40–60% of all nosocomial
S. aureus infections. MRSA was usually viewed as a cause of nos-
ocomial infection [2]. However, within the past 10 years, it has be-
come an increasing threat to not only hospitals but also community
settings [3,4].
Community-associated MRSA (CA-MRSA) isolates established
infections in patients without traditional MRSA risk factors [5–8]
and shared common molecular characteristics which are different
from healthcare-associated MRSA (HA-MRSA) isolates [6–9]. How-
ever, CA-MRSA clones varied in different continents, countries and
even areas. CA-MRSA strains are now endemic in many US
hospitals [5,7],and about two-thirdsofsevereHA-MRSA infections
were community-onset [10]. It is likely that these patients returned
hospital settings through emergency department (ED).
In Taiwan, MRSA was first documented in early 1980s and
rapidly increased in 1990s, accounting for 53–83% of all S. aureus
isolates in most hospitals of Taiwan in 2000s [11]. In addition,
CA-MRSA infections have been increasingly reported in pediatric
patients since 2000 [12,13].
Colonization of Staphylococcus aureus strains may serve as endo-
genous reservoirs for subsequent clinical infections [14,15], and
the risk was even higher for MRSA. Since patients visiting the
emergency department (ED) may come from different settings, we
aimed to determine in this study the prevalence of Staphylococcus
aureus and MRSA nasal colonization among the patients visiting
ED, and further to identify the risk factors for acquisition and
microbiologic characteristics of MRSA. Such information can
provide the extent of MRSA in ED, thus shaping strategies for
prevention and treatment of MRSA, both in the hospital and
community.
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Chang Gung Memorial Hospital is a university-affiliated 3000-
bed tertiary teaching hospital situated in northern Taiwan. It pro-
vides primary care, secondary care, and tertiary care. Approximately
15000 patients visited the ED eachmonth. This study was approved
by the Institutional Review Board of Chang Gung Memorial Hos-
pital. From May 21 to August 12, 2009, patients aged above 18
years old visiting ED of Chang Gung Memorial Hospital were
invited and surveyed for nasal carriage of MRSA after a written
consent was obtained. A questionnaire regarding the risk factors for
MRSA acquisition was also obtained.
Laboratory methods
Nasal swab samples were collected with sterile swabs from both
anterior nares, then placed in the transport medium (Venturi
Transystem, Copan Innovation Ltd., Limmerick, Ireland) and sent
to microbiological laboratory for culture. Swabs were plated by
streak plate method on Blood Agar Plate Isolates of S. aureus and
MRSA identification by oxacillin susceptibility with the disc diffu-
sion methods were confirmed according to the recommendations
of Clinical and Laboratory Standards Institute [16].
Antimicrobial susceptibility testing
The susceptibility of MRSA isolates to 9 antibiotics including
doxycyclin,vancomycin, teicoplanin,penicillin,trimethoprim/sulfa-
methoxazole, erythromycin, chloramphenicol, linezolid, and fusidic
acid was determined using the disk-diffusion method according
to the recommendations of Clinical and Laboratory Standards
Institute [16].
Molecular typing
Chromosomal DNAs were extracted from MRSA isolates for
molecular characterization. Pulsed-field gel electrophoresis (PFGE)
was used to fingerprint all MRSA isolates according to the pro-
cedure described previously [13,17]. Staphylococcal chromosome
cassette mec (SCCmec) type, and the presence of Panton-Valentine
leukocidin (PVL) genes were determined by PCR assays according
to the procedure described previously [13,17,18]. Multilocus
sequence typing (MLST) was performed for selective strains of
representative PFGE patterns as described elsewhere [19].
Questionnaire and Statistical analysis
Each participant, with or without the assist of their family, was
requested to complete a questionnaire regarding risk factors for
MRSA colonization. Demographic and clinical data were collected.
Demographic data included age, gender, education level, social
economic status, and smoking habits. High social economic level
was defined by having both high school diploma and/or monthly
salary exceeding NT 50000. Those who do not fulfill either
conditions were classified as low social economic level. Clinical
information regarding chief complaint for this visit to ED, recent
hospitalization or outpatient department visit, dialysis, current
usage of tubes (nasogastric tube, urine catheter, tracheostomy tube,
drainage tube, port-A, and dialysis tube), chronic underlying di-
sease, and recent antibiotic use within one year of enrollment were
obtained. The details of their recent hospitalization history, labo-
ratory tests, and antibiotic use were further obtained by medical
chart review.
Patients with a history of hospitalization, surgery, dialysis, or
residence in a long-term care facility within 1 year of enrollment, a
permanent indwelling catheter or percutaneous medical device
(eg, tracheostomy tube, gastrostomy tube, or Foley catheter), or a
known positive culture for MRSA prior to the study [6] were
classified into the group with risk factors for MRSA acquisition.
Those without any of the above factors were the group without
risk factors.
Statistics
The categorical data was examined by chi-square test or logistic
regression model using SPSS 16.0 statistical software. A p value
,0.05 indicated a significant difference statistically. Risk factors
associated with MRSA colonization with a p value,0.05 were
subsequently included for further multivariate logistic regression
model.
Results
A total of 502 adult patients were enrolled in this study. 268
patients (53%) were male. The majority of the patients were over
60 years of age and the age distribution was 55(11%) patients
between 19–29 years, 212 (42%) between 30–59 years and 235
(47%) over 60 years. 219 patients (44%) were classified into the
group with risk factors and 283 patients the group without risk
factors.
The overall prevalence of methicillin sensitive S. aureus and
MRSA nasal carriage were 13.5% and 3.8%, respectively. The
overall carriage rate of S. aureus was 17.3%. The carriage rate of S.
aureus and MRSA, respectively, among the patients with risk
factors were significantly higher than that of those without risk
factors (p=0.033, respectively) (Table 1).
The association of demographic and clinical factors with MRSA
colonization is shown in Table 2. Univariate analysis revealed that
diabetes mellitus, chronic kidney disease, current usage of
percutaneous catheters or tubes, and urinary complaint for this
visit were significant risk factors for MRSA colonization. After
multivariate logistic regression analysis, only current usage of
catheters or tubes (p=0.025) was the independent predictor for
MRSA colonization (Table 3). Patients more than 60 years of age
Table 1. Comparison of nasal Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) colonization rate between adult
patients with and without risk factors.
Colonized subjects No. (%) of subjects
Odds Ratio [95%
confidence interval] p value
With risk factor Without risk factor Total
Subject No. 219 283 502
S. aureus 47(21.4) 40(14.1) 87 (17.3) 1.667(1.047–2.653) 0.033
MRSA 13 (5.9) 6 (2.1) 19 (3.8) 2.924(1.093–7.822) 0.033
doi:10.1371/journal.pone.0018620.t001
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Demographic and clinical data No. (%) of subjects Odds ratio 95% confidence interval p value
a
MRSA(n=19) Non-MRSA(n=483)
Male 7(36.8) 261(54.0) 0.496 0.192–1.282 0.141
Age
19–29 0(0) 55(11.3) 1 0.939–0.976 0.997
30–59 6(31.5) 206(42.6) 0.621 0.232–1.660 0.342
.=60 13(68.4) 222(45.9) 2.547 0.952–6.813 0.062
Education level
Elementary school 13(68.4) 221(45.7) 2.569 0.96–6.87 0.06
Junior and high school 4(21.0) 186(38.5) 0.426 0.139–1.303 0.124
Colleagues 2(10.5) 76(15.7) 0.63 0.143–2.783 0.539
Low social economic status
b 17(89.4) 419(86.7) 1.298 0.293–5.753 0.73
Smoking habit
non-smoker 13(68.4) 281(58.1) 1.558 0.582–4.167 0.378
ex-smoker 4(21.0) 110(22.7) 0.904 0.294–2.780 0.861
current smoker 2(10.5) 92(19.0) 0.5 0.114–2.202 0.36
Underlying diseases
DM 9(47.3) 115(23.8) 3.174 1.231–8.186 0.017*
Heart disease 4(21.0) 99(20.4) 1.102 0.355–3.423 0.866
Hypertension 10(52.6) 190(39.3) 1.914 0.742–4.938 0.179
CVD 3(15.7) 65(13.4) 1.28 0.361–4.544 0.703
Liver disease 2(10.5) 77(15.9) 0.656 0.148–2.910 0.576
Biliary system disease 0(0) 13(2.6) 1 0.946–0.98 0.48
Asthma 1(5.2) 30(6.2) 0.884 0.114–6.872 0.906
COPD 0(0) 13(2.6) 1 0.946–0.98 0.48
Bronchiectasis 0(0) 7(1.4) 1 0.947–0.98 0.606
Cancer 6(31.5) 102(21.1) 1.858 0.681–5.071 0.22
Allergic rhinitis 2(10.5) 36(7.4) 1.545 0.342–6.985 0.569
CKD 5(26.3) 48(9.9) 3.47 1.186–10.152 0.023*
Chronic seizure disease 1(5.2) 10(2.0) 2.771 0.335–22.894 0.324
Autoimmune disease 0(0) 8(1.6) 1 0.945–0.979 0.572
TB 0(0) 17(3.5) 1 0.940–0.978 0.395
Other risk factors
Duration of previous hospitalization within 1 year
Never 8(42.1) 292(60.4) 0.418 (0.165–1.061) 0.066
,7 days 5(26.3) 68(14.0) 2.059 (0.718–5.902) 0.17
.7 days 6(31.5) 99(20.4) 1.683 (0.624–4.541) 0.299
Culture during last hospitalization
c
No 15(78.9) 390(80.7) 0.692 0.223–2.146 0.524
Other bacteria 3(15.7) 62(12.8) 1.21 0.343–4.272 0.767
S. aureus 1(5.2) 10(2.0) 2.511 0.305–20.69 0.376
Current usage of catheters or tubes
d 7(36.8) 59(12.2) 4.192 1.587–11.071 0.002*
Current usage of NG tubes 1(5.3) 1(0.2) 1.733 0.217–13.850 0.599
Current antibiotics use 7(36.8) 165(34.1) 1.124 0.434–2.91 0.809
Antibiotics within a year 12(63.1) 211(43.6) 2.21 0.855–5.710 0.102
Dialysis 2(10.5) 17(3.5) 0.116 0.689–15.088 0.116
Chief complaint
e
Respiratory 1(5.2) 78(16.1) 0.288 0.038–2.192 0.23
Gastrointestinal 5(26.3) 137(28.3) 0.902 0.319–2.552 0.846
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trend toward MRSA colonization. The patients not hospitalized
within one year had a trend against MRSA colonization.
The molecular characterization of all 19 MRSA isolates is
shown in Table 4. A total of six PFGE were identified with three
major patterns (type A, 21%; type C, 32% and type D, 26%). Most
MRSA isolates belonged to two lineages as sequence type (ST) 59
and ST 239. ST 59 linage was further classified into two clones,
characterized as PFGE C/SCCmec IV/PVL-negative and PFGE
D/SCCmec VT/PVL-positive. These two clones accounted for
83% of 6 isolates from patients without risk factors, and are
community-associated (CA) clones in Taiwan.
All 19 MRSA isolates were susceptible to vancomycin, linezoid,
teicoplanin, and fusidic acid. Susceptibility to trimethoprim-
sulfamethoxazoe (TMP-SMX), clindamycin, doxycyclin, and
erythromycin was detected in 73.7%, 21.0%, 68.4%, and 21.0%
of the isolates, respectively. For the 6 isolates from patients without
risk factors, the susceptibilities to clindamycin, doxycyclin, and
erythromycin were significantly higher than those of the isolates
from patients with risk factors.(P=0.041, P=0.05, P=0.041,
respectively) (Table 5).
Discussion
Results from this study indicated that the nasal carriage rate of
MRSA among the adult patients visiting the ED of a medical
center in northern Taiwan was 3.78%, a rate significantly higher
than that among patients admitted to hospitals in the Netherlands
(0.03% during 1999–2000) [20] and that among general
population in the US (1.5% during 2003–2004) [21]. Compared
with previous reports from Taiwan, the rate was significantly lower
than that for adult patients hospitalized in ICUs (32%) [22] but
Demographic and clinical data No. (%) of subjects Odds ratio 95% confidence interval p value
a
MRSA(n=19) Non-MRSA(n=483)
Urinary 4(21.0) 32(6.6) 3.758 1.178–11.986 0.017*
skin superficial infection 1(5.2) 26(5.3) 0.976 0.125–7.601 0.982
other systemic symptoms 8(42.1) 210(43.4) 0.945 0.374–2.392 0.906
aFisher’s exact test instead of Pearson’s chi-square test was performed when any expected count was less than 5 by statistical analysis.
bLow social economic status was defines as patients other than those with education level above senior high and a monthly income more than 50,000 NT.
cIncluding wound or surgical site culture, blood culture, sputum culture, and urine culture.
dIncluding Foley, port A, percutaneous drainage tubes, and catheter for dialysis.
eThe chief complaints were classified according to the systems of the body affected.
doi:10.1371/journal.pone.0018620.t002
Table 2. Cont.
Table 3. Comparison of nasal Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) colonization rate between subjects
using catheters/tubes or not.
Carrier No.(%) of subjects
Odds Ratio[95%
confidence interval] p value
subjects using
catheters or tubes
subjects not using
catheters or tubes Total
Subject No. 66 436 502
MRSA 7(10.6) 12(2.8) 19(3.8) 4.192(1.587–11.071) 0.002
S. aureus 21(31.8) 66(15.1) 87(17.3) 2.616(1.464–4.674) 0.001
doi:10.1371/journal.pone.0018620.t003
Table 4. Distribution of PFGE pattern and other molecular characteristics of 19 methicillin-resistant Staphylococcus aureus,
stratified by with or without risk factors.
Characteristics No.(%)of isolates A B C D F BM
Without risk factors 6 (31.5) 1 (16.6) 0 2 (33.3) 3 (50) 0 0
With risk factors 13 (68.4) 3 (23.0) 2 (15.3) 4 (30.7) 2 (15.3) 1(7.6) 1(7.6)
T o t a l 1 9 42651 1
MLST types 239 239 59 59 5 45
SCCmec type III* III* IV VT II UT
PVL genes-positive 00050 0
*included its variants IIIa and IIIb.
MLST, multilocus sequence type; SCCmec, staphylococcal chromosome cassette type; PVL, Panton-Valentine leukocidin; UT, untypeable.
doi:10.1371/journal.pone.0018620.t004
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examination [23,24]. Patients visiting emergency department may
come from both community settings and healthcare facilities.
Therefore, the expected nasal MRSA carriage rate among these
patients should be higher than that among the community
subjects, but it is not the case in the present study. The carriage
rate was nearly same for both populations. Since it was harder to
get access to patients with severe medical condition, we might
collect samples from subjects that held characters more close to
those in the community settings. However, the carriage rate was
significantly higher in the patients with risk factors (5.94%) than
those without risk factors (2.12%) (Table 1). Further studies are
needed to confirm this finding, since nasal MRSA carriage was
only identified in 19 individuals in the present study.
In the current study, 58% of MRSA isolates belonged to ST 59
linage, which included several clones with two major clones (PFGE
C/SCCmec IV/PVL-negative and PFGE D/SCCmec VT/PVL-
positive) and were community strains in Taiwan [13,25], and the
rate was even up to 83% of the isolates from those without risk
factors for MRSA acquisition. In contrast, about 30% of MRSA
isolates belonged to ST 239 linage, which was among worldwide
epidemic clones as well as healthcare associated clones in Taiwan
[17,25]. Likewise, the isolates from the patients with risk factors
were resistant to more antibiotics than those from patients without
risk factors. These results were compatible with our assumption
that patients visiting emergency department may come from both
community settings and healthcare facilities. The issue whether
CA-MRSA strain will become widespread, even in health-care
facilities, in Taiwan needs further observation [26,27].
In the current study usage of percutaneous catheters or tubes
was identified as the only independent predictor for MRSA
colonization. Whether biofilm-forming capacity of S. aureus on
various indwelling devices assists its persistence in the host needs
further studies. Wang et al found that smoking was a protective
factor against MRSA colonization in the community setting [24],
which was not confirmed in this study.
In conclusion, 3.78% of patients visiting the ED of a medical
centerinnorthernTaiwanin2009harboredMRSAinnares.Usage
of percutaneous catheters or tubes was significantly associated with
MRSA colonization. Most of the isolates belonged to ST59 linage, a
community clone in Taiwan. Nasal MRSA colonization among
patients visiting ED may accelerate the spread of MRSA both in the
community and healthcare-associated settings.
Perspectives
Colonization of MRSA, compared with MSSA colonization,
was 4-fold more likely to develop invasive infection [15]. To avoid
invasive infection among the colonized ones, prevention strategies
have to be made. Several studies have shown that elimination of
nasal carriage reduces the incidence of Staphylococcus aureus, and the
carriage from other body sites usually disappeared after the nasal
carriage has been treated [28–30]. Intervention strategies included
decolonization with topical treatment (eg. mupirocin ointment to
eradicate nasal carriage, tea tree oil and chlorhexidine gluconate
to eradicate cutaneous carriage), oral probiotic preparation con-
taining lactobacillus and occasional systemic antimicrobial agents
[31,32]. Nevertheless, widespread use of antibacterial agents may
elicit the development of resistance. Since the relative risk of
developing invasive infection after carriage is linked to the clinical
comorbidities [15], carriage eradication is necessary in the hos-
pitalized patients, especially those at high risk of MRSA acquisition
as mentioned in the present study. Recent study has shown that
nasal wash with water and use of nasal sprays was associated with
significant decrease of Staphylococcus aureus colonization rate [33].
However, its clinical practicality requires further investigation.
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